Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Perez

Showing results (251-260 of 261) with videos related to

Pageof 27
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|November 30, 2025
A Large-Scale Analysis of Autologous Stem Cell Transplantation for Multiple Myeloma Patients Older than 65 YearsAdolfo Jesús Sáez-Marín, Gema Hernandez-Ibarbu, Lucia Medina Alba, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2021
Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I TrialMartin Hutchings, Franck Morschhauser, Gloria Iacoboni, et al.
Journal of Participatory Medicine|May 22, 2026
Developing a Culturally Tailored Narrative Video for Skin Cancer Prevention Among Spanish-Speaking Hispanic Outdoor Workers: Co-Design StudyDavid Perez, Valeria Gómez, Dariana Sedeño-Delgado, et al.
Angewandte Chemie (International Ed. in English)|May 27, 2021
Infrared Based Saliva Screening Test for COVID-19Bayden R Wood, Kamila Kochan, Diana E Bedolla, et al.
Nature Communications|February 27, 2024
Q586B2 is a crucial virulence factor during the early stages of Trypanosoma brucei infection that is conserved amongst trypanosomatidsBenoit Stijlemans, Patrick De Baetselier, Inge Van Molle, et al.
Oncoimmunology|April 14, 2017
MEDI1873, a potent, stabilized hexameric agonist of human GITR with regulatory T-cell targeting potentialNatalie J Tigue, Lisa Bamber, John Andrews, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2016
SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal CancerGuy A van Hazel, Volker Heinemann, Navesh K Sharma, et al.
Expert Opinion on Pharmacotherapy|March 5, 2026
Low-dose oral minoxidil (LDOM) and topical minoxidil: consensus recommendations for managing male and female pattern Hair loss in Hair transplant patients using a modified delphi processAditya K Gupta, Mesbah Talukder, Greg Williams, et al.
Faraday Discussions|June 11, 2016
Single cell analysis/data handling: general discussionMatthew J Baker, Royston Goodacre, Christopher Sammon, et al.
Faraday Discussions|June 11, 2016
Clinical Spectroscopy: general discussionRoyston Goodacre, Valter Sergo, Hugh Barr, et al.
Pageof 27

Showing results (251-260 of 261) with videos related to

Sort By:
Pageof 27
Clinical Lymphoma, Myeloma & Leukemia|November 30, 2025
A Large-Scale Analysis of Autologous Stem Cell Transplantation for Multiple Myeloma Patients Older than 65 YearsAdolfo Jesús Sáez-Marín, Gema Hernandez-Ibarbu, Lucia Medina Alba, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2021
Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I TrialMartin Hutchings, Franck Morschhauser, Gloria Iacoboni, et al.
Journal of Participatory Medicine|May 22, 2026
Developing a Culturally Tailored Narrative Video for Skin Cancer Prevention Among Spanish-Speaking Hispanic Outdoor Workers: Co-Design StudyDavid Perez, Valeria Gómez, Dariana Sedeño-Delgado, et al.
Angewandte Chemie (International Ed. in English)|May 27, 2021
Infrared Based Saliva Screening Test for COVID-19Bayden R Wood, Kamila Kochan, Diana E Bedolla, et al.
Nature Communications|February 27, 2024
Q586B2 is a crucial virulence factor during the early stages of Trypanosoma brucei infection that is conserved amongst trypanosomatidsBenoit Stijlemans, Patrick De Baetselier, Inge Van Molle, et al.
Oncoimmunology|April 14, 2017
MEDI1873, a potent, stabilized hexameric agonist of human GITR with regulatory T-cell targeting potentialNatalie J Tigue, Lisa Bamber, John Andrews, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2016
SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal CancerGuy A van Hazel, Volker Heinemann, Navesh K Sharma, et al.
Expert Opinion on Pharmacotherapy|March 5, 2026
Low-dose oral minoxidil (LDOM) and topical minoxidil: consensus recommendations for managing male and female pattern Hair loss in Hair transplant patients using a modified delphi processAditya K Gupta, Mesbah Talukder, Greg Williams, et al.
Faraday Discussions|June 11, 2016
Single cell analysis/data handling: general discussionMatthew J Baker, Royston Goodacre, Christopher Sammon, et al.
Faraday Discussions|June 11, 2016
Clinical Spectroscopy: general discussionRoyston Goodacre, Valter Sergo, Hugh Barr, et al.
Pageof 27